세계의 호르몬 피임약 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Hormonal Contraceptives Market is presumed to reach the market size of nearly USD 35.85 Billion by 2032 from USD 23.35 Billion in 2023 with a CAGR of 4.88% under the study period 2024-2032.

Hormonal contraceptives are common methods of birth control. It contains man-made estrogen and progesterone in small amounts. The main purpose of hormonal contraceptives is to disrupt normal hormone balance, suppress ovulation and prevent pregnancy. Hormonal contraceptives come in various forms, namely vaginal ring, hormone-releasing contraceptive coils, skin patches and birth control pill. It is also used to manage polycystic ovary syndrome (PCOS) and is safe and reliable. Hormonal contraceptives are categorized as combination hormonal contraceptives and progestin-only contraceptives. Combined hormonal contraceptives are high in demand due to better efficacy and availability. Distribution channels include gynecology centers, ambulatory surgical centers, hospitals, clinics, and home care.

MARKET DYNAMICS

Increasing awareness related to the use and benefits of hormonal contraceptives, especially in emerging economies, and increasing incidence of unwanted pregnancies are acting as key drivers for global hormonal contraceptive market growth. Other factors that contribute to its market growth are unstable relationships, women opting to prioritize their careers, the increasing number of menstruating population, and the need for controlling population growth. Furthermore, partnerships between companies for R&D to develop hormonal contraceptives with better efficacy and government awareness programs related to sexual health are likely to fuel market growth. However, the side effects of hormonal contraceptives, availability of hormone-free contraceptives, preference for biologics, and lack of social acceptability are restraining hormonal contraceptive market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hormonal Contraceptives. The growth and trends of Hormonal Contraceptives industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hormonal Contraceptives market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

• Pill
• Intrauterine Device (IUD)
• Injectable
• Vaginal Ring
• Implant
• Patch

By Hormone

• Combination Hormonal Contraceptives
• Progestin Only

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hormonal Contraceptives market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hormonal Contraceptives market include Abbvie Inc., Afaxys Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Merck & Co. Inc., Organon Group Of Companies, Pfizer, Agile Therapeutics, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Pregna International Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HORMONAL CONTRACEPTIVES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Method
  • 3.7.2 Market Attractiveness Analysis By Hormone
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY METHOD

• 5.1. Overview By Method
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Method
• 5.4. Pill Historic and Forecast Sales By Regions
• 5.5. Intrauterine Device (IUD) Historic and Forecast Sales By Regions
• 5.6. Injectable Historic and Forecast Sales By Regions
• 5.7. Vaginal Ring Historic and Forecast Sales By Regions
• 5.8. Implant Historic and Forecast Sales By Regions
• 5.9. Patch Historic and Forecast Sales By Regions

6. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY HORMONE

• 6.1. Overview By Hormone
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Hormone
• 6.4. Combination Hormonal Contraceptives Historic and Forecast Sales By Regions
• 6.5. Progestin Only Historic and Forecast Sales By Regions

7. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HORMONAL CONTRACEPTIVES COMPANIES

• 8.1. Hormonal Contraceptives Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF HORMONAL CONTRACEPTIVES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Abbvie Inc.
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Afaxys Inc.
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Teva Pharmaceuticals Industries Ltd.
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Bayer AG
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Merck & Co. Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Organon Group Of Companies
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Pfizer
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. Agile Therapeutics
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Janssen Pharmaceuticals Inc.
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Lupin Pharmaceuticals Inc.
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Pregna International Ltd
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies